Scott Wolchko To Retire as President and CEO after 10 years of Leadership in Pioneering iPSC-derived Cellular Immunotherapies SAN DIEGO, Nov. 29, 2024 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc.
The global CAR-T Cell Therapy market size is expected to reach USD 8.92 billion by 2026 growing at a CAGR of 34.5% from 2020 to 2026 according to a new study published by Report Ocean. Request To ...
Herpes simplex virus (HSV), the viral agent causing human genital herpes, recurs easily and poses significant harm to patients, while also being associated with atherosc ...
Researchers published a dataset covering thousands of methylated sites from hundreds of cancer-derived cultured cells, covering many leukemias, lymphomas and myelomas, from humans and mice. With this ...
China NMPA accepts Akeso's sNDA penpulimab combination therapy for first-line treatment of hepatocellular carcinoma: Hong Kong Monday, November 25, 2024, 13:00 Hrs [IST] Akeso, In ...